7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,898.90

-132.50

-3.29%

77,782.31

+317.31

+0.41%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

NYSE American - Delayed Quote USD

Impact BioMedical Inc. (IBO)

3.8000 -0.0700 (-1.81%)

At close: October 30 at 4:00:00 PM EDT

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

DSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical’s Proposed Business Combination with Zoar Limited

GlobeNewswire 1mo ago

IBO
-1.81%
DSS
Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited)

GlobeNewswire 1mo ago

IBO
-1.81%
CORRECTED — Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited)

GlobeNewswire 1mo ago

IBO
-1.81%
Impact BioMedical Inc (NYSE American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (previously Dr. Ashley’s Ltd.)

GlobeNewswire 1mo ago

IBO
-1.81%
Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans

GlobeNewswire 6mo ago

IBO
-1.81%

Performance Overview

Return	IBO	S&P 500 (^GSPC)
YTD	-40.55%	+10.73%
1-Year	-42.93%	+11.11%
3-Year	-89.99%	+81.91%

Mobilize your Website

View Site in Mobile | Classic

Share by: